Bath & Body Works (NYSE:BBWI) Price Target Raised to $22.00

Key Points

• UBS raised its price target on Bath & Body Works to $22 from $17, maintaining a neutral rating; the target implies 2.64% upside from the prior close.
• Analyst sentiment is broadly cautious: MarketBeat reports a consensus Hold rating and an average target of $22.53, with 15 Hold, 4 Buy, and 1 Sell ratings.
• The company beat quarterly earnings expectations, posting $0.62 per share versus $0.24 expected, while revenue of $1.51 billion topped forecasts but fell 2.3% year over year.

Bath & Body Works (NYSE:BBWI - Get Free Report) had its price objective raised by equities researchers at UBS Group from $17.00 to $22.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a "neutral" rating on the stock. UBS Group's target price suggests a potential upside of 2.64% from the stock's previous close.

BBWI has been the subject of several other reports. Citigroup raised Bath & Body Works from a "neutral" rating to a "buy" rating and set a $25.00 price objective for the company in a research note on Tuesday, August 18th. Wells Fargo & Company lifted their target price on Bath & Body Works from $24.00 to $25.00 and gave the company an "overweight" rating in a research note on Thursday, October 29th. JPMorgan Chase & Co. boosted their target price on Bath & Body Works from $22.00 to $24.00 and gave the company a "neutral" rating in a report on Tuesday, August 18th. Robert W. Baird cut their price target on Bath & Body Works from $25.00 to $23.00 and set a "neutral" rating for the company in a research note on Thursday, August 27th. Finally, Morgan Stanley cut their price target on Bath & Body Works from $22.00 to $20.00 and set an "equal weight" rating for the company in a research note on Thursday, August 27th. Four equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $22.53.

Bath & Body Works Trading Up 1.7%

NYSE:BBWI traded up $0.35 during midday trading on Friday, reaching $21.43. The company had a trading volume of 1,505,969 shares, compared to its average volume of 5,949,377. Bath & Body Works has a 12-month low of $14.27 and a 12-month high of $24.94. The firm has a market capitalization of $4.32 billion, a price-to-earnings ratio of 5.58, a PEG ratio of 1.09 and a beta of 1.31. The stock's fifty day simple moving average is $19.16 and its 200-day simple moving average is $19.82.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Wednesday, August 26th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.24 by $0.38. Bath & Body Works had a net margin of 10.83% and a negative return on equity of 53.48%. The company had revenue of $1.51 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter in the previous year, the business posted $0.30 EPS. The firm's revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, sell-side analysts expect that Bath & Body Works will post 2.74 EPS for the current year.

Institutional Investors Weigh In On Bath & Body Works

A number of large investors have recently added to or reduced their stakes in the business. AlphaGrep UK Ltd grew its stake in shares of Bath & Body Works by 104.0% during the 3rd quarter. AlphaGrep UK Ltd now owns 32,381 shares of the company's stock valued at $516,000 after purchasing an additional 16,510 shares during the period. Focus Advisor Solutions LLC lifted its stake in shares of Bath & Body Works by 13.8% in the 3rd quarter. Focus Advisor Solutions LLC now owns 28,139 shares of the company's stock worth $448,000 after purchasing an additional 3,419 shares during the period. South Dakota Investment Council lifted its stake in shares of Bath & Body Works by 11.6% in the 3rd quarter. South Dakota Investment Council now owns 2,113,720 shares of the company's stock worth $33,650,000 after purchasing an additional 219,832 shares during the period. Rothschild Investment LLC boosted its holdings in shares of Bath & Body Works by 12.5% in the third quarter. Rothschild Investment LLC now owns 7,570 shares of the company's stock worth $121,000 after buying an additional 841 shares during the last quarter. Finally, Edgestream Partners L.P. purchased a new position in shares of Bath & Body Works in the third quarter worth approximately $2,586,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.